Erste Asset Management Gmb H Chimerix Inc Transaction History

Erste Asset Management Gmb H

  • $8.35 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 26, 2024
SELL
$0.94 - $1.23 $113,740 - $148,830
-121,000 Closed
0 $0
Q3 2022

Nov 26, 2024
BUY
$1.81 - $2.76 $219,010 - $333,960
121,000 New
121,000 $224 Million
Q2 2022

Nov 26, 2024
BUY
$1.34 - $5.34 $162,140 - $646,140
121,000 New
121,000 $249 Million
Q1 2022

Nov 22, 2024
BUY
$4.58 - $6.8 $554,180 - $822,800
121,000 New
121,000 $558 Million
Q4 2021

Nov 22, 2024
BUY
$5.23 - $7.18 $209,200 - $287,200
40,000 New
40,000 $270 Million

Others Institutions Holding CMRX

# of Institutions
72
Shares Held
38.4M
Call Options Held
52.7K
Put Options Held
130K
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $362M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email